Sr One Capital Management, LP / DSGN
Sr One Capital Management, LP’s Design Therapeutics Inc Position
Does Sr One Capital Management, LP own Design Therapeutics Inc (DSGN)? Yes — 6.53M shares worth $69M (+7.59% of its 13F portfolio) as of Q1 2026.
Position Value
$69M
Q1 2026
Shares
6.53M
% of Portfolio
+7.59%
Quarters Held
18
currently held
Position History DSGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 6.53M | $69M | +7.59% |
| Q4 2025 | 6.53M | $61M | +8.67% |
| Q3 2025 | 6.53M | $49M | +7.11% |
| Q2 2025 | 6.53M | $22M | +4.77% |
| Q1 2025 | 6.53M | $25M | +6.47% |
| Q4 2024 | 6.53M | $40M | +9.82% |
| Q3 2024 | 6.53M | $35M | +7.04% |
| Q2 2024 | 6.53M | $22M | +6.85% |
| Q1 2024 | 6.53M | $26M | +7.22% |
| Q4 2023 | 6.53M | $17M | +7.26% |
| Q3 2023 | 6.53M | $15M | +7.89% |
| Q2 2023 | 6.53M | $41M | +17.73% |
| Q1 2023 | 6.53M | $38M | +14.03% |
| Q4 2022 | 6.53M | $67M | +24.44% |
| Q3 2022 | 5.63M | $94M | +43.01% |
| Q2 2022 | 5.63M | $79M | +38.55% |
| Q1 2022 | 5.63M | $91M | +46.52% |
| Q4 2021 | 5.63M | $120M | +68.08% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sr One Capital Management, LP’s full portfolio or all institutional holders of DSGN.